All Stories

  1. Rapid Two-Step Multicomponent Synthesis and Structure-degradation Relationships of Selective HDAC6 PROTAC Degraders
  2. Integrating Toxicological Intelligence into Global E-waste Governance: From Material Recovery to Health-protective Circularity
  3. Membrane‐Active Peptide Protects Against Inflammation by Targeting NLRP3 Activation at the Trans‐Golgi Network
  4. Design, synthesis and biological evaluation of novel pyrimidine and quinazoline-based small-molecule Toll-like receptor 8 antagonists
  5. Drug-Metabolizing Enzymes in Human Keratinocytes and In Vitro Detection of Cytochrome P450-Mediated Phenolic Lamotrigine Metabolite
  6. Impact of Processing Delays and Cryopreservation on Sensitivity and Specificity of the Lymphocyte Transformation Test
  7. Defining positivity in the lymphocyte transformation test with cytokine read-out: What is the best of bad choices?
  8. Crosstalk between NLRP3 Signaling and Histone Deacetylases in Inflammasome-Driven Diseases
  9. Structure-guided approaches to modulate endosomal toll-like receptors TLR7, TLR8 and TLR9: advances, challenges and therapeutic promise
  10. Trans-kingdom conservation of mechanism between bacterial actifensin and eukaryotic defensins
  11. The monomeric but not homotrimeric spike protein of SARS-CoV-2 activates TLR4 signaling
  12. Optimization of 6-(trifluoromethyl)pyrimidine derivatives as TLR8 antagonists
  13. The vasoconstrictor adenosine 5′-tetraphosphate is a danger signal that induces IL-1β
  14. Discovery of Novel Isoxazole-Based Small-Molecule Toll-Like Receptor 8 Antagonists
  15. Degrading the key component of the inflammasome: development of an NLRP3 PROTAC
  16. Lipopolysaccharide-Neutralizing Peptide Modulates P2X7 Receptor-Mediated Interleukin-1β Release
  17. Degrading the key component of the inflammasome: Development of an NLRP3 PROTAC
  18. Development of the First-in-Class Degrader of NLRP3
  19. Label-free biosensor assay decodes the dynamics of Toll-like receptor signaling
  20. Groebke Blackburn Bienaymé-mediated multi-component synthesis of selective HDAC6 inhibitors with anti-inflammatory properties
  21. Label-free biosensor assay decodes the dynamics of Toll-like receptor signaling
  22. Groebke Blackburn Bienaymé-mediated multi-component synthesis of selective HDAC6 inhibitors with anti-inflammatory properties
  23. P2X7 receptor activation leads to NLRP3-independent IL-1β release by human macrophages
  24. A Comparison between SARS-CoV-2 and Gram-Negative Bacteria-Induced Hyperinflammation and Sepsis
  25. Groebke Blackburn Bienaymé-mediated multi-component synthesis of selective HDAC6 inhibitors with anti-inflammatory properties
  26. Pharmacological inhibition of HDAC6 suppresses NLRP3 inflammasome-mediated IL-1β release
  27. A Comparison between SARS-CoV-2 and Gram-Negative Bacteria-Induced Hyperinflammation and Sepsis
  28. Toxicological and Safety Pharmacological Profiling of the Anti-Infective and Anti-Inflammatory Peptide Pep19-2.5
  29. Anti-Infective and Anti-Inflammatory Mode of Action of Peptide 19-2.5
  30. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
  31. Immunocompetent Human Intestinal Models in Preclinical Drug Development
  32. An update on endotoxin neutralization strategies in Gram-negative bacterial infections
  33. TatS: a novel in vitro tattooed human skin model for improved pigment toxicology research
  34. Biological Characterization, Mechanistic Investigation and Structure‐Activity Relationships of Chemically Stable TLR2 Antagonists
  35. The novel small-molecule antagonist MMG-11 preferentially inhibits TLR2/1 signaling
  36. Lysosomotropic beta blockers induce oxidative stress and IL23A production in Langerhans cells
  37. Identification and characterization of a novel chemotype for human TLR8 inhibitors
  38. LPS-neutralizing peptides reduce outer membrane vesicle-induced inflammatory responses
  39. Intracellular Lipopolysaccharide Sensing as a Potential Therapeutic Target for Sepsis
  40. Synthetic Anti-lipopolysaccharide Peptides (SALPs) as Effective Inhibitors of Pathogen-Associated Molecular Patterns (PAMPs)
  41. Identification of a pyrogallol derivative as a potent and selective human TLR2 antagonist by structure-based virtual screening
  42. Inhibition of Lipopolysaccharide- and Lipoprotein-Induced Inflammation by Antitoxin Peptide Pep19-2.5
  43. Antimicrobial endotoxin-neutralizing peptides promote keratinocyte migration via P2X7 receptor activation and accelerate wound healing in vivo
  44. Antimicrobial Peptides and Their Therapeutic Potential for Bacterial Skin Infections and Wounds
  45. Characterization of reconstructed human skin containing Langerhans cells to monitor molecular events in skin sensitization
  46. Glucocorticoids and Toll-like receptor 2 cooperatively induce acute-phase serum amyloid A
  47. Synthetic anti-endotoxin peptides inhibit cytoplasmic LPS-mediated responses
  48. Cell type-specific regulatory effects of glucocorticoids on cutaneous TLR2 expression and signalling
  49. Biotransformation of 2,4-toluenediamine in human skin and reconstructed tissues
  50. Recognition of Propionibacterium acnes by human TLR2 heterodimers
  51. Synthetic antimicrobial and LPS-neutralising peptides suppress inflammatory and immune responses in skin cells and promote keratinocyte migration
  52. Sphingosine 1-phospate differentially modulates maturation and function of human Langerhans-like cells
  53. Acute myeloid leukaemia-derived Langerhans-like cells enhance Th1 polarization upon TLR2 engagement
  54. Erratum
  55. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)
  56. IL-4 abrogates T H 17 cell-mediated inflammation by selective silencing of IL-23 in antigen-presenting cells
  57. Inflammatory conditions distinctively alter immunological functions of Langerhans-like cells and dendritic cellsin vitro
  58. Regulation of Dendritic Cell Function in Inflammation
  59. Chloroquine Promotes IL-17 Production by CD4+T Cells via p38-Dependent IL-23 Release by Monocyte-Derived Langerhans-like Cells
  60. Impact of structural differences in hyperbranched polyglycerol–polyethylene glycol nanoparticles on dermal drug delivery and biocompatibility
  61. Core-multishell nanotransporters enhance skin penetration of the cell-penetrating peptide low molecular weight protamine
  62. Cationic membrane-active peptides - anticancer and antifungal activity as well as penetration into human skin
  63. TLR2/1 and sphingosine 1-phosphate modulate inflammation, myofibroblast differentiation and cell migration in fibroblasts
  64. Increased cutaneous absorption reflects impaired barrier function of reconstructed skin models mimicking keratinisation disorders
  65. Improving Topical Non-Melanoma Skin Cancer Treatment: In vitro Efficacy of a Novel Guanosine-Analog Phosphonate
  66. 9 Mucosal Immunology in Candida albicans Infection
  67. Esterase activity in excised and reconstructed human skin – Biotransformation of prednicarbate and the model dye fluorescein diacetate
  68. Glycosylation of Candida albicans Cell Wall Proteins Is Critical for Induction of Innate Immune Responses and Apoptosis of Epithelial Cells
  69. Host Defence Against Candida albicans and the Role of Pattern-recognition Receptors
  70. Interaction of the mucosal barrier with accessory immune cells during fungal infection
  71. 3D-Wound healing model: Influence of morphine and solid lipid nanoparticles
  72. The Candida albicans cell wall protein Rhd3/Pga29 is abundant in the yeast form and contributes to virulence
  73. Epithelial Cells and Innate Antifungal Defense
  74. Susceptibility testing of amorolfine, bifonazole and ciclopiroxolamine againstTrichophyton rubrumin anin vitromodel of dermatophyte nail infection
  75. Influences of opioids and nanoparticles on in vitro wound healing models
  76. Models of Oral and Vaginal Candidiasis Based on In Vitro Reconstituted Human Epithelia for the Study of Host-Pathogen Interactions
  77. Introduction: Host Responses
  78. Susceptibility testing of amorolfine, bifonazole and ciclopiroxolamine against Trichophyton rubrum in an in vitro model of dermatophyte nail infection
  79. Charakterisierung der Interaktion zwischen Candida albicans und Wirtszellen
  80. Quantitative expression of the Candida albicans secreted aspartyl proteinase gene family in human oral and vaginal candidiasis
  81. Human epithelial cells establish direct antifungal defense through TLR4-mediated signaling
  82. Crosstalk between Keratinocytes and Adaptive Immune Cells in an IκBα Protein-Mediated Inflammatory Disease of the Skin
  83. The Early Transcriptional Response of Human Granulocytes to Infection with Candida albicans Is Not Essential for Killing but Reflects Cellular Communications
  84. Models of oral and vaginal candidiasis based on in vitro reconstituted human epithelia
  85. Retinoids in the treatment of skin aging: an overview of clinical efficacy and safety
  86. In vivo Porphyrin Production by P. acnes in Untreated Acne Patients and its Modulation by Acne Treatment
  87. Receptor-Selective Retinoids for Psoriasis
  88. Stroma-Mediated Dysregulation of Myelopoiesis in Mice Lacking IκBα
  89. Peroxisome Proliferator-Activated Receptors and their Ligands
  90. Induction of Nuclear Factor–κB and c‐Jun/Activator Protein–1 via Toll‐Like Receptor 2 in Macrophages by Antimycotic‐TreatedCandida albicans
  91. Hyaluronic Acid in the Treatment and Prevention of Skin Diseases: Molecular Biological, Pharmaceutical and Clinical Aspects
  92. Toll-like receptors as key mediators in innate antifungal immunity